Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Loss of HLA Class-I Expression In Leukemic Cells That Relapsed After HLA-Matched and -Mismatched SCT

Yukio Kondo, MD, PhD, Takamasa Katagiri, Bsc, Kohei Hosokawa, MD, Kinya Ohata, MD, Hirohito Yamazaki, MD, PhD, Seishi Ogawa, MD, PhD, Shinji Nakao, MD, PhD

Blood (2010) 116 (21): 2541.

https://doi.org/10.1182/blood.V116.21.2541.2541

Published: 2010

Journal Articles

GITR Ligation with GITR Ligand On Leukemic Cells Suppresses Induction of Leukemia-Associated Antigen Specific T Cells by Increasing Indoleamine 2, 3-Dioxygenase (IDO) Activity Leading to Kynurenine Secretion.

Yukio Kondo, MD, PhD, Luis Espinoza, MD, PhD, Takamasa Katagiri, PhD, Zhirong Qi, MD, Shinji Nakao, MD, PhD

Blood (2009) 114 (22): 3557.

https://doi.org/10.1182/blood.V114.22.3557.3557

Published: 2009

Journal Articles

GITR Ligand on Leukemic Myeloid Dendritic Cells Suppresses Induction of Leukemia-Associated Antigen-Specific CTLs from Naïve CD8 + T Cells.

Yukio Kondo, MD, PhD, Takamasa Katagiri, PhD, Kinya Ohata, MD, Shinji Nakao, MD, PhD

Blood (2008) 112 (11): 2347.

https://doi.org/10.1182/blood.V112.11.2347.2347

Published: 2008

Journal Articles

The FcγRllla Polymorphism Correlates with Chronic Graft-Versus-Host Disease and Treatment Related Mortality.

Akiyoshi Takami, MD, PhD, J. Luis Espinoza, MD, Ken Ishiyama, MD, PhD, Satomi Ohyachi, Yuki Kato, Yoshimi Kawamura, Yukio Kondo, MD, PhD, Shizuka Yasue, Shigeki Ohtake, MD, PhD, Shinji Nakao, MD, PhD

Blood (2008) 112 (11): 2237.

https://doi.org/10.1182/blood.V112.11.2237.2237

Published: 2008

Journal Articles

A Novel Strategy for the Treatment of Acute Graft-Versus-Host Disease Using the Adsorbent To Remove Excessive Inflammatory Cytokines.

Akiyoshi Takami, MD, PhD, Takanori Teshima, MD, PhD, Koshin Ushizaki, Takumi Taniguchi, MD, PhD, Tohru Endo, Hiroshi Sakurai, PhD, Yukio Kondo, MD, PhD, Hirohito Yamazaki, MD, PhD, Shigeru Shimadoi, MD, Hirokazu Okumura, MD, PhD, Shinji Nakao, MD, PhD

Blood (2007) 110 (11): 5001.

https://doi.org/10.1182/blood.V110.11.5001.5001

Published: 2007

Journal Articles

Monocyte Colony-Stimulating Factor Enhances Rituximab-Dependent Cellular Cytotoxicity by Monocytes.

Akiyoshi Takami, MD, PhD, FJSIM, Shigeru Shimadoi, MD, Yukio Kondo, MD, PhD, Hirokazu Okumura, MD, PhD, Shinji Nakao, MD, PhD

Blood (2006) 108 (11): 2533.

https://doi.org/10.1182/blood.V108.11.2533.2533

Published: 2006

NARROW

Loss of HLA Class-I Expression In Leukemic Cells That Relapsed After HLA-Matched and -Mismatched SCT

GITR Ligation with GITR Ligand On Leukemic Cells Suppresses Induction of Leukemia-Associated Antigen Specific T Cells by Increasing Indoleamine 2, 3-Dioxygenase (IDO) Activity Leading to Kynurenine Secretion.

GITR Ligand on Leukemic Myeloid Dendritic Cells Suppresses Induction of Leukemia-Associated Antigen-Specific CTLs from Naïve CD8 + T Cells.

The FcγRllla Polymorphism Correlates with Chronic Graft-Versus-Host Disease and Treatment Related Mortality.

A Novel Strategy for the Treatment of Acute Graft-Versus-Host Disease Using the Adsorbent To Remove Excessive Inflammatory Cytokines.

Monocyte Colony-Stimulating Factor Enhances Rituximab-Dependent Cellular Cytotoxicity by Monocytes.

Email alerts

ASH Publications

American Society of Hematology

Loss of HLA Class-I Expression In Leukemic Cells That Relapsed After HLA-Matched and -Mismatched SCT

GITR Ligation with GITR Ligand On Leukemic Cells Suppresses Induction of Leukemia-Associated Antigen Specific T Cells by Increasing Indoleamine 2, 3-Dioxygenase (IDO) Activity Leading to Kynurenine Secretion.

GITR Ligand on Leukemic Myeloid Dendritic Cells Suppresses Induction of Leukemia-Associated Antigen-Specific CTLs from Naïve CD8 + T Cells.

The FcγRllla Polymorphism Correlates with Chronic Graft-Versus-Host Disease and Treatment Related Mortality.

A Novel Strategy for the Treatment of Acute Graft-Versus-Host Disease Using the Adsorbent To Remove Excessive Inflammatory Cytokines.

Monocyte Colony-Stimulating Factor Enhances Rituximab-Dependent Cellular Cytotoxicity by Monocytes.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only